Open original FDA record ↗Recall record
- FDA identifier
- Z-1339-2012
- Company in FDA record
- Fresenius Medical Care Holdings, Inc.
- FDA classification date
- Mar 30, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Risk of internal blood leaks affecting the hemodialyzers.
Source facts
- Action
- Fresenius North America notified consignees on 3/6/12 by recall notification letter titled:Urgent FMCNA Optiflux F160NRe Hemodialyzer Recall, by certified mail with return receipt. The letter identified the affected product and described the reason for the recall. Customers were instructed to examine their stock immediately to determine whether they have any of the affected lot on hand. If customers have the affected lot, they have been instructed to immediately discontinue use and place all unused units in a secure area for return to Fresenius Medical Care North America. A Reply Response from is to be completed and returned. Customers have been instructed to contact their Fresenius Medical Care Customer Service Team for instructions on how to return the recalled product. Contact 1-800-323-5188.
- Initiated
- 2012-03-06
- Root cause
- Process control
- Terminated
- 2016-08-08
- Distribution
- Nationwide Distribution
- Recall number
- Z-1339-2012
- Recall status
- Terminated
- CDRH record ID
- 107744
- FDA classified
- 2012-03-30
- Recall event number
- 61293